{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:13:47Z","timestamp":1778822027510,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["No.ZRMS2023001143"],"award-info":[{"award-number":["No.ZRMS2023001143"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["ZRMS2023001143"],"award-info":[{"award-number":["ZRMS2023001143"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112097","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:32:56Z","timestamp":1714177976000},"page":"112097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association between ascites Gustave Roussy immune score and the intratumoural microbiome in malignant ascites secondary to hepatocellular carcinoma"],"prefix":"10.1016","volume":"133","author":[{"family":"ShanTian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-5984","authenticated-orcid":false,"given":"Weiguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.intimp.2024.112097_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814404","article-title":"Hepatocellular carcinoma prevention in the era of hepatitis C elimination","volume":"24","author":"Lazarus","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"38","key":"10.1016\/j.intimp.2024.112097_b0010","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"D'Souza","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.112097_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112097_b0020","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/JHC.S404424","article-title":"Egyptian society of liver cancer recommendation guidelines for the management of hepatocellular carcinoma","volume":"10","author":"Omar","year":"2023","journal-title":"J. Hepatocell Carcinoma"},{"issue":"9","key":"10.1016\/j.intimp.2024.112097_b0025","doi-asserted-by":"crossref","first-page":"pgad280","DOI":"10.1093\/pnasnexus\/pgad280","article-title":"Mechanism of ozone alleviation of malignant ascites in hepatocellular carcinoma through the inhibition of neutrophil extracellular traps","volume":"2","author":"Han","year":"2023","journal-title":"PNAS Nexus"},{"issue":"7","key":"10.1016\/j.intimp.2024.112097_b0030","first-page":"2073","article-title":"A survey of treatment approaches of malignant ascites in Germany and Austria","volume":"23","author":"Jehn","year":"2015","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112097_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.25453","article-title":"Palliation of malignant ascites","volume":"120","author":"Hodge","year":"2019","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112097_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-023-02798-8","article-title":"Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites","volume":"42","author":"Hrvat","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2024.112097_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.08.012","article-title":"The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.112097_b0050","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/HEP.0000000000000427","article-title":"Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC","volume":"78","author":"Li","year":"2023","journal-title":"Hepatology (BaltimoreMd.)"},{"issue":"7","key":"10.1016\/j.intimp.2024.112097_b0055","doi-asserted-by":"crossref","first-page":"e1331","DOI":"10.1002\/ctm2.1331","article-title":"Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery","volume":"13","author":"Sun","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"13","key":"10.1016\/j.intimp.2024.112097_b0060","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1007\/s00432-023-04962-1","article-title":"Identification of a brand intratumor microbiome signature for predicting prognosis of hepatocellular carcinoma","volume":"149","author":"Song","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.112097_b0065","doi-asserted-by":"crossref","first-page":"1195499","DOI":"10.3389\/fonc.2023.1195499","article-title":"Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study","volume":"13","author":"Shangguan","year":"2023","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112097_b0070","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1245\/s10434-022-12226-4","article-title":"Changes in the Gustave Roussy immune score as a powerful prognostic marker of the therapeutic sensitivity of nivolumab in advanced gastric cancer: a multicenter","volume":"29","author":"Nakazawa","year":"2022","journal-title":"Retrospective Study. Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.intimp.2024.112097_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14740\/wjon1184","article-title":"Gustave Roussy immune score is a prognostic factor for chemotherapy-naive pulmonary adenocarcinoma with wild-type epidermal growth factor receptor","volume":"10","author":"Minami","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.intimp.2024.112097_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737283","article-title":"Gustave Roussy immune score as a novel prognostic scoring system for colorectal cancer patients: a propensity score matching analysis","volume":"11","author":"Tian","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2024.112097_b0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.07.027","article-title":"Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)","volume":"84","author":"Bigot","year":"2017","journal-title":"Eur. J. Cancer (Oxford, England : 1990)"},{"issue":"10","key":"10.1016\/j.intimp.2024.112097_b0090","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41416-023-02214-0","article-title":"Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma","volume":"128","author":"Ma","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112097_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijsu.2020.10.015","article-title":"Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: a propensity score matching retrospective cohort study","volume":"84","author":"Li","year":"2020","journal-title":"Int. J. Surg."},{"issue":"6","key":"10.1016\/j.intimp.2024.112097_b0100","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.7150\/jca.37898","article-title":"Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma","volume":"11","author":"Feng","year":"2020","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2024.112097_b0105","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1002\/cam4.5294","article-title":"The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: a multicenter retrospective analysis","volume":"12","author":"Hatanaka","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2024.112097_b0110","article-title":"Development and validation of a prognostic score for hepatocellular carcinoma patients in immune checkpoint inhibitors therapies: the hepatocellular carcinoma modified Gustave Roussy immune score","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112097_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112423","article-title":"Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions","volume":"249","author":"Zhang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.112097_b0120","doi-asserted-by":"crossref","first-page":"1249910","DOI":"10.3389\/fphar.2023.1249910","article-title":"Synergistic effect of Euphorbia kansui stir-fried with vinegar and bile acids on malignant ascites effusion through modulation of gut microbiota","volume":"14","author":"Dai","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112097_b0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-023-05602-9","article-title":"Levels of systemic inflammation response index are correlated with tumor-associated bacteria in colorectal cancer","volume":"14","author":"Cao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112097_b0130","article-title":"Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses","author":"Wang","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112097_b0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fimmu.2014.00427","article-title":"The intestinal microbiome in early life: health and disease","volume":"5","author":"Arrieta","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112097_b0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fimmu.2014.00318","article-title":"Blowing on embers: commensal microbiota and our immune system","volume":"5","author":"Spasova","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112097_b0145","doi-asserted-by":"crossref","first-page":"e0227707","DOI":"10.1371\/journal.pone.0227707","article-title":"Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer","volume":"15","author":"Miao","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2024.112097_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10051005","article-title":"The Gustave Roussy immune (GRIm)-score variation is an early-on-treatment biomarker of outcome in advanced non-small cell lung cancer (NSCLC) patients treated with first-line pembrolizumab","volume":"10","author":"Lenci","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.112097_b0155","article-title":"Improving patient selection for immuno-oncology phase 1 trials: external validation of six prognostic scores in a French Cancer Center","author":"Al Darazi","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2024.112097_b0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-8709-2_6","article-title":"Multiplex immunohistochemistry for image analysis of tertiary lymphoid structures in cancer","volume":"1845","author":"Steele","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112097_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043086","article-title":"Multiplex immunofluorescence: a powerful tool in cancer immunotherapy","volume":"24","author":"Sheng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2024.112097_b0170","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/gutjnl-2020-322196","article-title":"High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells","volume":"70","author":"Liu","year":"2021","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.intimp.2024.112097_b0175","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00262-019-02427-4","article-title":"Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma","volume":"68","author":"Langhans","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2024.112097_b0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","article-title":"T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma","volume":"77","author":"Barsch","year":"2022","journal-title":"J. Hepatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:53:15Z","timestamp":1778820795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"alternative-id":["S1567576924006155"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112097","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between ascites Gustave Roussy immune score and the intratumoural microbiome in malignant ascites secondary to hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112097"}}